Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

8.3%

2 terminated out of 24 trials

Success Rate

89.5%

+3.0% vs benchmark

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

24%

4 of 17 completed with results

Key Signals

4 with results89% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (12)
P 1 (3)
P 2 (4)
P 4 (1)

Trial Status

Completed17
Unknown4
Terminated2
Recruiting1

Trial Success Rate

89.5%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT03202641Not ApplicableTerminated

Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients

NCT06502002Not ApplicableCompleted

Dexmedetomidine Infusion and Postoperative Lung Aeration After Thoracic Surgery

NCT06900426Not ApplicableCompletedPrimary

Lung Atelectasis Improvement Through Positive End Expiratory Pressure During Anesthetic Induction

NCT03764319Not ApplicableCompleted

Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With ARDS and ECMO

NCT04289324Not ApplicableRecruiting

Open Lung Maneuvers During High Frequency Oscillatory Ventilation in Preterm Infants

NCT04511923Phase 1Completed

Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury

NCT04344184Phase 2Completed

SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)

NCT05680831Phase 1UnknownPrimary

Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air

NCT05647967UnknownPrimary

Features of Regional Perfusion of Lung Consolidation

NCT05647382Not ApplicableCompleted

Soluble VE-cadherin in Prediction and Diagnosis of Early Postoperative Hypoxemia After Cardiopulmonary Bypass

NCT05610475Not ApplicableCompletedPrimary

Serum Level of Calpains Product as a Novel Biomarker of Acute Lung Injury Following Cardiopulmonary Bypass

NCT03905837Phase 4Completed

Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery

NCT04499378Unknown

Tomographic Findings in COVID-19 and Influenza H1N1

NCT03651817Not ApplicableCompletedPrimary

Lung Protection Strategy in Open Heart Surgery: Which Tidal Volume is Better 8ml/kg or 6ml/kg

NCT03828630Completed

Lung Ultrasound to Detect Pulmonary Complications in Critically Ill Parturients

NCT03023670Not ApplicableCompletedPrimary

Lung Protection and Pediatric Cardiac Surgery

NCT03637530Not ApplicableUnknownPrimary

a Study Conducted About a New Mode of Ventilation in Laparoscopic Surgeries

NCT00996840Phase 2CompletedPrimary

SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS

NCT01597635Phase 2CompletedPrimary

The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury

NCT01640990Phase 1CompletedPrimary

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers

Scroll to load more

Research Network

Activity Timeline